Cancer cachexia and protein metabolism
- PMID: 6145877
- DOI: 10.1016/s0140-6736(84)91929-9
Cancer cachexia and protein metabolism
Abstract
Metabolic abnormalities arising from malnutrition and malignancy are seen in patients with cancer cachexia. To discriminate between the effects of pure malnutrition and tumour-specific metabolic alterations, the kinetics of whole-body metabolism were determined in 7 untreated, malnourished cancer patients and in 11 patients with benign disease, also malnourished, by means of primed constant infusion of 15N-glycine. Patients in both groups received 500 kcal/day as 5% glucose solution without any nitrogen. Whole-body protein turnover was 32% and 35% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Similarly, the rate of protein synthesis was 35% and 54% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Our study supports the view that aberrations of host metabolism in patients with cancer cachexia are different from those in non-cancer patients suffering equivalent weight loss.
Similar articles
-
Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease.JPEN J Parenter Enteral Nutr. 1988 May-Jun;12(3):229-36. doi: 10.1177/0148607188012003229. JPEN J Parenter Enteral Nutr. 1988. PMID: 3134558
-
Cancer cachexia and the rate of whole body lipolysis in man.Metabolism. 1986 Apr;35(4):304-10. doi: 10.1016/0026-0495(86)90145-9. Metabolism. 1986. PMID: 3959902
-
Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.Cancer. 1998 Jan 1;82(1):42-8. Cancer. 1998. PMID: 9428478
-
Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.Crit Rev Clin Lab Sci. 1993;30(3):223-72. doi: 10.3109/10408369309084669. Crit Rev Clin Lab Sci. 1993. PMID: 8260072 Review.
-
Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumor interaction.JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6 Suppl):60S-64S. doi: 10.1177/014860719201600605. JPEN J Parenter Enteral Nutr. 1992. PMID: 1287226 Review.
Cited by
-
Effect of growth hormone on tumor and host in an animal model.Ann Surg Oncol. 1994 Jul;1(4):314-20. doi: 10.1007/BF02303570. Ann Surg Oncol. 1994. PMID: 7850530
-
Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.Antibodies (Basel). 2019 Dec 4;8(4):56. doi: 10.3390/antib8040056. Antibodies (Basel). 2019. PMID: 31817205 Free PMC article. Review.
-
Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.Endocrinology. 2008 Sep;149(9):4589-95. doi: 10.1210/en.2008-0259. Epub 2008 Jun 5. Endocrinology. 2008. PMID: 18535106 Free PMC article.
-
Metabolic alteration in patients with cancer: nutritional implications.Surg Today. 1998;28(3):247-57. doi: 10.1007/s005950050116. Surg Today. 1998. PMID: 9548304 Review.
-
Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.Br J Clin Pharmacol. 2020 Sep;86(9):1769-1777. doi: 10.1111/bcp.14369. Epub 2020 Jun 11. Br J Clin Pharmacol. 2020. PMID: 32424951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources